Neonc Technologies (NASDAQ:NTHI) Announces Earnings Results

Neonc Technologies (NASDAQ:NTHI) issued its quarterly earnings data on Monday. The company reported ($0.58) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.12) by ($0.46), Zacks reports.

Neonc Technologies Stock Performance

Shares of Neonc Technologies stock opened at $3.50 on Tuesday. Neonc Technologies has a fifty-two week low of $3.01 and a fifty-two week high of $12.99. The business has a fifty day simple moving average of $4.16 and a 200-day simple moving average of $6.21.

Wall Street Analysts Forecast Growth

NTHI has been the subject of several recent analyst reports. Maxim Group began coverage on Neonc Technologies in a research note on Monday, May 18th. They set a “buy” rating and a $20.00 target price for the company. Weiss Ratings downgraded shares of Neonc Technologies from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, June 24th. BTIG Research reissued a “buy” rating and issued a $15.00 price target on shares of Neonc Technologies in a report on Tuesday, May 26th. Finally, Alliance Global Partners assumed coverage on shares of Neonc Technologies in a research note on Tuesday, May 19th. They set a “buy” rating and a $13.00 target price for the company. Three equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $16.00.

Hedge Funds Weigh In On Neonc Technologies

Several hedge funds have recently made changes to their positions in the business. 683 Capital Management LLC bought a new stake in Neonc Technologies during the fourth quarter worth approximately $442,000. OMERS ADMINISTRATION Corp acquired a new stake in shares of Neonc Technologies during the 4th quarter valued at $126,000. Barclays PLC lifted its position in shares of Neonc Technologies by 5,314.8% during the 4th quarter. Barclays PLC now owns 9,151 shares of the company’s stock valued at $76,000 after acquiring an additional 8,982 shares during the last quarter. State Street Corp boosted its stake in shares of Neonc Technologies by 9.9% during the 4th quarter. State Street Corp now owns 43,170 shares of the company’s stock worth $357,000 after acquiring an additional 3,900 shares in the last quarter. Finally, Goldman Sachs Group Inc. acquired a new position in shares of Neonc Technologies in the 4th quarter worth $124,000.

About Neonc Technologies

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.